| abstract |
An object of the present invention is to provide an anti-obesity agent effective for preventing, improving or treating obesity. An anti-obesity agent containing a glutaminase inhibitor as an active ingredient. The glutaminase inhibitor is preferably 6-diazo-5-oxo-L-norleucine [(S) -2-amino-6-diazo-5-oxocaproic acid or a salt thereof (DON)], or CB-839. . Anti-obesity agents are used in foods and drinks and pharmaceuticals. [Selection diagram] None |